Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,301,419
+$981,456 QoQ
Shares Held
1,873,293
-8.5% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 136 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. NKTX ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in NKTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,301,419 | 1,873,293 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,319,963 | 2,047,376 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,798,166 | 971,982 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,076,756 | 520,172 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $451,456 | 271,962 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $398,245 | 216,438 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $507,369 | 203,763 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,477,967 | 326,984 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,610,251 | 441,667 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,682,469 | 248,147 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $923,637 | 139,945 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $239,461 | 109,343 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $462,490 | 130,279 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,271,455 | 212,263 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,221,802 | 168,830 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,569,241 | 370,880 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $357,354 | 31,402 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,984,463 | 129,281 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $238,637 | 8,581 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||